Preliminary results of the phase 1 trial with the Delta24RGD oncolytic adenovirus, administered by CED in patients with recurrent Glioblastoma

被引:0
|
作者
Dirven, Clemens M. F. [1 ]
机构
[1] Erasmus MC, Rotterdam, Netherlands
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
INV086
引用
收藏
页码:A20 / A20
页数:1
相关论文
共 50 条
  • [1] A CHIMERIC ONCOLYTIC ADENOVIRUS CIRCUMVENTS NEUTRALIZING ANTIBODIES DEVELOPED BY PATIENTS WITH RECURRENT GLIOBLASTOMA TREATED WITH DELTA-24-RGD
    Shin, Dong Ho
    Jiang, Hong
    Gillard, Andrew
    Fan, Xuejun
    Singh, Sanjay
    Lopez-Rivas, Andres
    He, Jiasen
    Gumin, Joy
    Lang, Frederick
    Gomez-Manzano, Candelaria
    Fueyo-Margareto, Juan
    [J]. NEURO-ONCOLOGY, 2023, 25
  • [2] Phase I clinical trial in patients with recurrent gliomas: delta-24-RGD oncolytic adenovirus induces an antiglioma immune-response
    Fueyo, J.
    Gomez-Manzano, C.
    Conrad, C.
    Heimberger, A.
    Vence, L.
    Aldape, K.
    Yung, W. A.
    Sawaya, R.
    Fuller, G.
    Lang, F.
    [J]. JOURNAL OF NEUROLOGY, 2012, 259 : S46 - S46
  • [3] Convection Enhanced Delivery of the Oncolytic Adenovirus Delta24-RGD in Patients with Recurrent GBM: A Phase I Clinical Trial Including Correlative Studies
    van Putten, Erik H. P.
    Kleijn, Anne
    van Beusechem, Victor W.
    Noske, David
    Lamers, Cor H. J.
    de Goede, Anna L.
    Idema, Sander
    Hoefnagel, Daphna
    Kloezeman, Jenneke J.
    Fueyo, Juan
    Lang, Frederick F.
    Teunissen, Charlotte E.
    Vernhout, Rene M.
    Bakker, Cathy
    Gerritsen, Winald
    Curiel, David T.
    Vulto, Arnold
    Lamfers, Martine L. M.
    Dirven, Clemens M. F.
    [J]. CLINICAL CANCER RESEARCH, 2022, 28 (08) : 1572 - 1585
  • [4] TREATMENT OF PNETS WITH THE ONCOLYTIC ADENOVIRUS DELTA-24-RGD RESULTS IN ANTITUMOR EFFECT
    Garcia-Moure, Marc
    Martinez-Velez, Naiara
    Gonzalez-Huarriz, Marisol
    Puigdelloses, Montserrat
    Patino-Garcia, Ana
    Idoate, Miguel Angel
    Diez-Valle, Ricardo
    Tejada, Sonia
    Gomez-Manzano, Cande
    Fueyo, Juan
    Alonso, Marta M.
    [J]. NEURO-ONCOLOGY, 2017, 19 : 42 - 42
  • [5] THANK PHASE I TRIAL OF DNX-2440 ONCOLYTIC ADENOVIRUS IN PATIENTS WITH FIRST OR SECOND RECURRENCE OF GLIOBLASTOMA: PRELIMINARY RESULTS
    Perez-Larraya, J. Gallego
    de la Nava, D.
    Gonzalez-Huarriz, M.
    Garcia-Moure, M.
    Labiano, S.
    Zalacain, M.
    Marrodan, L.
    Ausejo, I.
    Laspidea, V.
    Hervas, I.
    Puigdelloses, M.
    Esparragosa, I.
    Giraldez, M.
    Serrano, M.
    Dominguez, P.
    Diez-Valle, R.
    Fueyo, J.
    Gomez-Manzano, C.
    Patino, A.
    Tejada, S.
    Bejarano, B.
    Alonso, M.
    [J]. NEURO-ONCOLOGY, 2023, 25
  • [6] Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma
    Lang, Frederick F.
    Conrad, Charles
    Gomez-Manzano, Candelaria
    Yung, W. K. Alfred
    Sawaya, Raymond
    Weinberg, Jeffrey S.
    Prabhu, Sujit S.
    Rao, Ganesh
    Fuller, Gregory N.
    Aldape, Kenneth D.
    Gumin, Joy
    Vence, Luis M.
    Wistuba, Ignacio
    Rodriguez-Canales, Jaime
    Villalobos, Pamela A.
    Dirven, Clemens M. F.
    Tejada, Sonia
    Valle, Ricardo D.
    Alonso, Marta M.
    Ewald, Brett
    Peterkin, Joanna J.
    Tufaro, Frank
    Fueyo, Juan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (14) : 1419 - +
  • [7] PRELIMINARY RESULTS OF A PHASE 1 TRIAL OF ORAL GALLIUM MALTOLATE IN RECURRENT GLIOBLASTOMA
    Connelly, Jennifer
    Zoss, Casey
    Schmainda, Kathleen
    Al-Gizawiy, Mona
    Pinheiro, Fernando Santos
    Chitambar, Christopher
    [J]. NEURO-ONCOLOGY, 2023, 25
  • [8] A Phase 1 Trial of Oncolytic Adenovirus ICOVIR-5 Administered Intravenously to Cutaneous and Uveal Melanoma Patients
    Garcia, Margarita
    Moreno, Rafael
    Gil-Martin, Marta
    Cascallo, Manel
    Ochoa de Olza, Maria
    Cuadra, Carmen
    Maria Piulats, Josep
    Navarro, Valentin
    Domenech, Marta
    Alemany, Ramon
    Salazar, Ramon
    [J]. HUMAN GENE THERAPY, 2019, 30 (03) : 352 - 364
  • [9] ONCOLYTIC ADENOVIRUS DELTA-24-RGD ENGINEERED TO EXPRESS 4-1BBL AS A THERAPEUTIC APPROACH FOR DIPG
    Laspidea, Virginia
    Puigdelloses, Montserrat
    Martinez-Velez, Naiara
    Garcia-Moure, Marc
    Labiano, Sara
    Ausejo, Iker
    Patino-Garcia, Ana
    Becher, Oren J.
    Jiang, Hong
    Gupta, Sumit
    Fueyo, Juan
    Gomez-Manzano, Candelaria
    Alonso, Marta M.
    [J]. NEURO-ONCOLOGY, 2020, 22 : 107 - 107
  • [10] IMMUNOMARKERS IN THE DNX-2401 (DELTA-24-RGD) ONCOLYTIC VIRUS PHASE I CLINICAL TRIAL
    Fueyo, Juan
    Gomez-Manzano, Candelaria
    Villalobos, Paloma
    Rodriguez-Canales, Jaime
    Wistuba, Ignacio
    Hess, Kenneth R.
    Alonso, Marta M.
    Tejada, Sonia
    Valle, Ricardo Diez
    Ewald, Brett
    Tufaro, Frank
    Lang, Fred
    [J]. NEURO-ONCOLOGY, 2017, 19 : 27 - 27